China’s economy grew just 4.5% in the last quarter of 2025, its slowest pace in three years.China’s economy grew just 4.5% in the last quarter of 2025, its slowest pace in three years.

China’s growth slumps to 3-year low despite Trump trade lift

China’s economy slowed to its weakest pace in three years as Donald Trump’s trade war highlighted the country’s heavy reliance on Western markets. Although the tariffs have since been lifted, major sectors are losing momentum.

China is one of the world’s biggest economies, but its gross domestic product softened to about 4.5% in the last quarter of 2025, the slowest in three years. The full-year growth was projected at 5%, matching Beijing’s target.

Even at a slower rate, China’s economy delivered results far better than some anticipated at the beginning of 2025. But sluggish growth reveals that China still has spending issues, particularly at home.

Those issues make it more difficult for families and businesses to succeed. Growth appears weaker in part because many factories and stores are under pressure due to weak domestic spending, even as sales abroad are strong. That means that while China sells a lot to other countries, people inside the country are not buying as much as previously.

Strong exports offset weak consumer activity at home

One of the biggest sources of strength for the Chinese economy in 2025 was exports. China set a record trade surplus of nearly $1.2 trillion last year. A trade surplus means the country sold more to other countries than it bought from them. 

This occurred even though Chinese exports to the United States fell by about 20% due to higher U.S. trade tariffs under President Donald Trump. But China made up for this by selling more to countries such as Africa, Southeast Asia, Europe, and Latin America.

Exports have been key to helping China reach its 2025 growth target. But domestic spending did not grow much. Consumers didn’t buy as much in stores, and many businesses didn’t build new factories or houses.

Since people are not spending more, the prices of many goods and services in China have remained the same or even fallen, leading to deflation. When people anticipate that prices will fall later, they may postpone spending, which slows economic growth.

On top of that, investment has been weak. Some forecasts indicate that fixed-asset investment, one of the largest parts of economic activity, fell or grew only slightly in 2025. These weak trends make it clear that the economy is unbalanced – exports are strong, but consumption and investment at home are slow.

China faces a tougher road ahead

Given these patterns, strong exports and weak domestic spending, many experts believe China will have to adjust its economic growth strategy. Leaders in Beijing have stated they want individuals to consume more goods and services domestically and depend less on exports. They are also trying to figure out how to promote company jobs and give people more freedom to spend. 

One idea is to lower interest rates so it is easier for businesses and families to borrow from banks. This could encourage individuals to purchase homes, start businesses, and spend more. China’s central bank has begun cutting some rates to help core industries like technology and agriculture, and could further boost the economy. Yet there are still dangers ahead. Growth is likely to slow further in 2026 to about 4.5%, and experts say that if exports slow, China will have to rely on other policies – including government spending – to promote the economy. 

Slow domestic spending, coupled with persistent deflation, also means China will need to make significant efforts to turn its economy around and put it on an upward trajectory. As a result, Chinese families and workers may expect fewer new jobs than before and slower income growth unless consumer confidence improves. Stores, eateries, and small businesses may still suffer if people continue to save rather than spend. Meanwhile, strong exports will remain a key factor in keeping the economy going.

Sharpen your strategy with mentorship + daily ideas - 30 days free access to our trading program

Market Opportunity
Polytrade Logo
Polytrade Price(TRADE)
$0.05947
$0.05947$0.05947
-0.35%
USD
Polytrade (TRADE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Buterin unveils Ethereum’s strategy to tackle quantum security challenges ahead. Ethereum focuses on simplifying architecture while boosting security for users. Ethereum’s market stability grows as Buterin’s roadmap gains investor confidence. Ethereum founder Vitalik Buterin has unveiled his long-term vision for the blockchain, focusing on making Ethereum quantum-secure while maintaining its simplicity for users. Buterin presented his roadmap at the Japanese Developer Conference, and splits the future of Ethereum into three phases: short-term, mid-term, and long-term. Buterin’s most ambitious goal for Ethereum is to safeguard the blockchain against the threats posed by quantum computing.  The danger of such future developments is that the future may call into question the cryptographic security of most blockchain systems, and Ethereum will be able to remain ahead thanks to more sophisticated mathematical techniques to ensure the safety and integrity of its protocols. Buterin is committed to ensuring that Ethereum evolves in a way that not only meets today’s security challenges but also prepares for the unknowns of tomorrow. Also Read: Ethereum Giant The Ether Machine Takes Major Step Toward Going Public! However, in spite of such high ambitions, Buterin insisted that Ethereum also needed to simplify its architecture. An important aspect of this vision is to remove unnecessary complexity and make Ethereum more accessible and maintainable without losing its strong security capabilities. Security and simplicity form the core of Buterin’s strategy, as they guarantee that the users of Ethereum experience both security and smooth processes. Focus on Speed and Efficiency in the Short-Term In the short term, Buterin aims to enhance Ethereum’s transaction efficiency, a crucial step toward improving scalability and reducing transaction costs. These advantages are attributed to the fact that, within the mid-term, Ethereum is planning to enhance the speed of transactions in layer-2 networks. According to Butterin, this is part of Ethereum’s expansion, particularly because there is still more need to use blockchain technology to date. The other important aspect of Ethereum’s development is the layer-2 solutions. Buterin supports an approach in which the layer-2 networks are dependent on layer-1 to perform some essential tasks like data security, proof, and censorship resistance. This will enable the layer-2 systems of Ethereum to be concerned with verifying and sequencing transactions, which will improve the overall speed and efficiency of the network. Ethereum’s Market Stability Reflects Confidence in Long-Term Strategy Ethereum’s market performance has remained solid, with the cryptocurrency holding steady above $4,000. Currently priced at $4,492.15, Ethereum has experienced a slight 0.93% increase over the last 24 hours, while its trading volume surged by 8.72%, reaching $34.14 billion. These figures point to growing investor confidence in Ethereum’s long-term vision. The crypto community remains optimistic about Ethereum’s future, with many predicting the price could rise to $5,500 by mid-October. Buterin’s clear, forward-thinking strategy continues to build trust in Ethereum as one of the most secure and scalable blockchain platforms in the market. Also Read: Whales Dump 200 Million XRP in Just 2 Weeks – Is XRP’s Price on the Verge of Collapse? The post Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! appeared first on 36Crypto.
Share
Coinstats2025/09/18 01:22
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26